Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 09, 2019

SELL
$10.88 - $17.6 $15.9 Million - $25.7 Million
-1,462,615 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$15.51 - $17.61 $10.8 Million - $12.3 Million
696,675 Added 90.96%
1,462,615 $25.8 Million
Q4 2018

Jan 30, 2019

BUY
$14.52 - $19.72 $11.1 Million - $15.1 Million
765,940 New
765,940 $13.3 Million

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Vaughan Nelson Investment Management, L.P. Portfolio

Follow Vaughan Nelson Investment Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan Nelson Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Vaughan Nelson Investment Management, L.P. with notifications on news.